Cargando…

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem

Antibody-mediated blockade of co-inhibitory molecules such as cytotoxic T lymphocyte-associated protein 4, PD1 and PDL1 elicits potent antitumor responses and improves the prognosis of many patients with cancer. As these immune checkpoint inhibitors (ICIs) are increasingly prescribed to a diverse pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poels, Kikkie, Neppelenbroek, Suzanne I.M., Kersten, Marie José, Antoni, M. Louisa, Lutgens, Esther, Seijkens, Tom T.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231062/ https://www.ncbi.nlm.nih.gov/pubmed/34168005 http://dx.doi.org/10.1136/jitc-2021-002916

Ejemplares similares

E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
por: Poels, Kikkie, et al.
Publicado: (2020)

Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease
por: Lutgens, Esther, et al.
Publicado: (2020)

Immuno-PET Imaging of Atherosclerotic Plaques with [(89)Zr]Zr-Anti-CD40 mAb—Proof of Concept
por: Poels, Kikkie, et al.
Publicado: (2022)

Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice
por: Poels, Kikkie, et al.
Publicado: (2020)

Statins and immune checkpoint inhibitors: a strategy to improve the efficacy of immunotherapy for cancer?
por: Vos, Winnie G, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis
por: Poels, Kikkie, et al.
Publicado: (2020)

The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
por: Bosmans, Laura A., et al.
Publicado: (2020)

Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability
por: Poels, Kikkie, et al.
Publicado: (2020)

The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017)

Cholesterol and Atherosclerotic Cardiovascular Disease: A Lifelong Problem
por: Gidding, Samuel S., et al.
Publicado: (2019)

Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis
por: Aarts, Suzanne ABM, et al.
Publicado: (2019)

Adipocytes control hematopoiesis and inflammation through CD40 signaling
por: Reiche, Myrthe E., et al.
Publicado: (2022)

Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions
por: Hoeksema, Marten A, et al.
Publicado: (2014)

Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients
por: Inno, Alessandro, et al.
Publicado: (2021)

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
por: Lameijer, Marnix, et al.
Publicado: (2018)

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
por: Roeters van Lennep, Jeanine E, et al.
Publicado: (2023)

Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8(+) T cell-mediated macrophage death
por: Seijkens, Tom T P, et al.
Publicado: (2019)

Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease
por: Lacy, Michael, et al.
Publicado: (2021)

Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia
por: Mszar, Reed, et al.
Publicado: (2023)

Emerging Therapies for the Treatment of Atherosclerotic Cardiovascular Disease: From Bench to Bedside
por: Kumric, Marko, et al.
Publicado: (2023)

Atherosclerotic Plaque Destabilization in Mice: A Comparative Study
por: Hartwig, Helene, et al.
Publicado: (2015)

‘Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity
por: Lith, Sanne C., et al.
Publicado: (2020)

Ablation of CD8α(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice
por: Legein, Bart, et al.
Publicado: (2015)

Inflammation in atherosclerotic cardiovascular disease
por: Shah, Prediman K., et al.
Publicado: (2019)

Atherosclerotic Cardiovascular Risk in Japan
por: Nojiri, Shuko, et al.
Publicado: (2017)

Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study
por: Wang, Charlie, et al.
Publicado: (2022)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events
por: Weber, Lauren A., et al.
Publicado: (2015)

Emerging Anti-Atherosclerotic Therapies
por: Gluba-Brzózka, Anna, et al.
Publicado: (2021)

The checkpoint ordering problem
por: Hungerländer, P.
Publicado: (2017)

Androgen therapy and atherosclerotic cardiovascular disease
por: McGrath, K-CY, et al.
Publicado: (2008)

Atherosclerotic Cardiovascular Disease Beginning in Childhood
por: Hong, Young Mi
Publicado: (2010)

The gut microbiome in atherosclerotic cardiovascular disease
por: Jie, Zhuye, et al.
Publicado: (2017)

Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada From 2002 to 2018
por: Mackinnon, Erin S., et al.
Publicado: (2021)

Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1
por: Ghai, Shruti, et al.
Publicado: (2023)

CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
por: Daub, Steffen, et al.
Publicado: (2020)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Cardiovascular magnetic resonance in carotid atherosclerotic disease
por: Dong, Li, et al.
Publicado: (2009)

Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
por: Wu, Hongxian, et al.
Publicado: (2018)

Social Network Structure and Atherosclerotic Cardiovascular Disease
por: Nishi, Nobuo
Publicado: (2018)

Incidence of cancers in patients with atherosclerotic cardiovascular diseases
por: Suzuki, Makoto, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_shg0fc94sueuuadp6c77r9ciul